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Available online 18 June 2016Context: Ficus capensis Thunb (Moraceae) is a medicinal plant widely grown in tropical and subtropical regions
with the leaf decoction commonly taken in traditional folklore as fertility agent in men for ages.
Aim: This study investigated the effects of aqueous extract from Ficus capensis leaves on angiotensin-I-converting
enzyme (ACE), acetylcholinesterase (AChE) and arginase activities in vitro. The antioxidant properties of the ex-
tract as typiﬁed by the abilities to scavenge radicals [nitric oxide (NO), hydroxyl (OH)], chelate Fe2+ and inhibit
Fe2+ -induced lipid peroxidation were also assessed.
Methods: The aqueous extract (1:10 w/v) of Ficus capensis leaves was prepared and the ability of the extract to
inhibit arginase, angiotensin I –converting enzyme (ACE), acetylcholinesterase (AChE) and antioxidant proper-
ties of the extract in rat’s penile tissue in vitrowas investigated using various spectrophotometric methods. Phe-
nolic constituent was carried-out using high performance liquid chromatography coupled with diode array
detection (HPLC - DAD).
Results: The extract inhibited ACE (IC50 = 52.17), AChE (IC50 = 172.60 μg/mL) and arginase (IC50 = 112.50 μg/
mL) activities in a dose-dependent pattern. Gallic acid, quercetin, caffeic acid, ellagic acid, rutin and chlorogenic
acid were the most abundant phenolic compounds identiﬁed in the sample. Furthermore, extract scavenged
NO (IC50 = 0.12 μg/mL) and OH (IC50 = 0.53 μg/mL) radicals, chelated Fe2+ (IC50 = 0.16 μg/mL) and inhibited
Fe2+ lipid peroxidation (IC50 = 435.17 μg/mL) dose-dependently.
Conclusion: Inhibition of ACE, AChE, arginase, Fe2+ -induced lipid peroxidation as well as radical scavenging and
Fe2+ -chelating abilities could be some of the possible mechanisms by which F. capensis leaves could be used in
the treatment/management of erectile dysfunction (ED).
© 2016 The Authors. Published by Elsevier GmbHon behalf of Society of Nutrition and Food Science e.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Erectile dysfunction (ED), which is deﬁned as the inability to achieve
and/or maintain penile erection sufﬁcient for satisfactory sexual perfor-
mance, is a widespread problem affecting many sexually active men
across all age groups [1]. Previous report has revealed that ED is preva-
lent in over 150 million men all over the world and has been predicted
to affect about 250 million men by 2025 [1]. Normal penile erection is a
function of neurovascular event, which depends on neural integrity, a
functional vascular system and healthy cavernosal tissue [2]. These sys-
tems are mediated by nitric oxide (NO) via the activation of NO-cyclic
guanosine monophosphate (cGMP) dilator pathway. The impairment
of this pathway by different factors could lead to ED [2].
Increased activity of arginase enzyme, a metalloenzyme that con-
verts L-arginine to urea and ornithine in a number of cells, has beenbH on behalf of Society of Nutrition aimplicated in the pathophysiology of ED [3]. Recent trends in the man-
agement of ED involve increase in NO levels with the use of arginase in-
hibitors. This is because in ED increase arginase activity limits NO
synthase activity and thereby reduces NO biosynthesis [4–6]. Report
has also shown that high blood pressure via inveterate change in
blood pressure which can alter the ﬂow of blood in penile vessels is an-
other causative factor ED [3]. Moreover, angiotensin-II, which is pro-
duced from the conversion of angiotensin-I in a reaction catalysed by
angiotensin-I-converting enzyme (ACE), is a potent vasoconstrictor ca-
pable of inducing vascular hypertrophy and endothelial dysfunction via
decrease in NO production [7]. Also, ACE activity deactivates the physi-
ological role of bradykinin, a vasodilator which has been implicated in
erectile function via the release of NO and relaxation of the corpus
cavernosum and consequently impair erectile function [8]. Likewise,
the enzyme acetylcholinesterase (AChE) is found in penile tissue [9].
The enzyme causes hydrolysis of acetylcholine (ACh), a neurotransmit-
ter reported to be involved in erectile function via the activation of en-
dothelial NO synthase and consequently release/produce NO enzymend Food Science e.V. This is an open access article under the CC BY-NC-ND license (http://
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in bioavailability of ACh restrains vascular relaxation and blood ﬂow in
erectile process [13]. Therefore, enhancement of ACh-producing system
could contribute to penile erection [8] and sexuality by stimulating the
penile cavernous nerves to evoke acetylcholine release [10–12], and in-
hibitor of AChE has been proven effective [9,13].
Oxidative stress has also been linked with ED due to excessive gener-
ation of free radicals in the penile (cavernosal) tissue [14]. Superoxide
combines with NO to form highly toxic peroxynitrite (NOO−); a culprit
in the initiation/formation of lipid peroxidation and oxidative stress
[15]. Oxidative stress in ED reduces the availability of NO which is re-
quired for penile erection [16]. Antioxidants are capable of reducing oxi-
dative stress by scavenging free radicals and, phenolics are the most
abundant antioxidants in plant based human diet such as fruits and veg-
etables [16]. Several studies have shown various relationships between
the consumption of polyphenol or polyphenol-rich foods and diseases
such as ED, diabetes, and cardiovascular and neurodegenerative diseases
[17].
Ficus capensis Thunb (Moraceae) also known as Ficus sur Forssk is a
medicinal plant widely grown in tropical and subtropical regions with
the leaf decoction commonly taken as fertility agent in men [18] and
for the treatment of dysentery, oedema, leprosy, epilepsy, rickets,
gonorrhoea, respiratory disorders and emollient [19]. The leaves of
F. capensis possess various pharmacological properties such as antioxi-
dant, anti-inﬂammation, and antimicrobial effects [20]. However,
there is dearth of information on the possible use of these plant leaves
or its extract in any form for the treatment/management of ED. Hence,
this study was designed to investigate the inhibitory effects of aqueous
extract from F. capensis leaves on key enzymes (ACE, AChE and argi-
nase) relevant to ED and its antioxidant potential.
2. Materials and methods
2.1. Chemical and reagent
Chemicals such as acetylthiocholine iodide, 5,5′-dithio-bis(2-
nitrobenzoic acid) (DTNB), thiobarbituric acid (TBA), trichloroacetic
acid (TCA), and 1,1-diphenyl-2 picrylhydrazyl (DPPH) were sourced
from Sigma-Aldrich, Chemie GmbH (Steinheim, Germany). Acetic acid
was procured from BDH Chemical Ltd., (Poole, England). Methanol, gal-
lic, chlorogenic, caffeic and ellagic acids, and catechin were purchased
from Merck (Darmstadt, Germany). Rutin, quercetin, quercitrin and
kaempferol were acquired from Sigma Chemical Co. (St. Louis, MO,
USA). Sodium carbonate, methanol, aluminium chloride, potassium ace-
tate, potassium ferricyanide, and ferric chloride were of analytical grade
while water was glass distilled. HPLC–DAD equipped with a Shimadzu
Prominence Auto Sampler (SIL-20A) HPLC system (Shimadzu, Kyoto,
Japan) and Shimadzu LC-20AT reciprocating pumps connected to a
DGU 20A5 degasser with a CBM 20A integrator, SPD-M20A diode array
detector and LC solution 1.22 SP1 software were used in this study.
Kenxin refrigerated centrifuge Model KX3400C was used while UV–Vis-
ible spectrophotometer (Model 6305; Jenway, Barloworld Scientiﬁc,
Dunmow, United Kingdom) was used to measure the absorbance.
2.2. Sample collection and preparation of aqueous extract
Fresh leaves of F. capensis were collected from a farm land around
Akure metropolis, Nigeria. The leaves were collected in May, 2015 and
authenticated at the Department of Plant Science, Ekiti State University
byMr F.OOmotayowith voucher numberUHAE 2015/31whichwasde-
posited in the university herbarium. The leaves were air dried at room
temperature and pulverized which was sieved in Willey 60 mesh size
and stored in a refrigerator. The powder sample was used for HPLC–
DAD analysis. Five grammes of the sample was soaked in 100mL of dis-
tilled water for about 24 h at 37 °C. The mixture was ﬁltered usingWhatman no. 1 and further centrifuged at 357.80 g for 10min to obtain
a clear supernatant which was used for subsequent analysis.
2.3. High performance liquid chromatography–diode array detector (HPLC)
analysis
Chromatographic analyses were carried out under gradient condi-
tions usingC18 column (4.6mm×150mm)packedwith 5 μmdiameter
particles in C18 (Phenomenex, Torrance, California); the mobile phase
was water containing 1% formic acid (A) and acetonitrile (B), and the
composition gradient was 13% of B until 10 min and changed to obtain
20, 30, 50, 60, 70, and 20, and 10% B at 20, 30, 40, 50, 60, 70, and
80 min, respectively [21]. F. capensis leaf extract and mobile phase
were ﬁltered through 0.45 μm membrane ﬁlter (Millipore, Billerica,
Massachusetts, USA) and then degassed by ultrasonic bath prior to
use; the extract was analysed at a concentration of 20 mg/mL. The
ﬂow rate was 0.7 mL/min, the injection volume was 40 μL, and the
wavelength in a photo-diode array detector — SPD-M204 was 254 nm
for gallic acid, 280 nm for catechin and epicatechin, 325 nm for
chlorogenic and ellagic acids, and 365 nm for quercetin, quercitrin,
isoquercitrin, rutin, and kaempferol. Stock solutions of standard refer-
ences were prepared in the HPLC mobile phase at a concentration
range of 0.030–0.250 mg/mL for kaempferol, quercetin, quercitrin,
isoquercitrin, rutin, catechin, and epicatechin and 0.050–0.450 mg/mL
for ellagic, gallic, and chlorogenic acids. Chromatography peaks were
conﬁrmed by comparing their retention time with those of reference
standards and by DAD spectra (200–500 nm). All chromatography op-
erations were carried out at ambient temperature and in triplicate [22].
2.4. Determination of total phenolic contents
The total phenol content of the extract was determined as described
by Singleton et al. [23]. Brieﬂy, appropriate dilution of the extract was
oxidized with 2.5 mL 10% Folin–Ciocalteau's reagent (v/v) and neutral-
ized by 2.0 mL of 7.5% NaCO3. The reaction mixture was incubated for
40 min at 45 °C and the absorbance was measured at 765 nm in the
spectrophotometer. Gallic acid was used as standard and the total phe-
nol content was subsequently calculated as gallic acid equivalent. The
total ﬂavonoid content was determined using a slightly modiﬁedmeth-
od [24]. Brieﬂy, 0.5 mL of appropriate diluted extract was mixed with
0.5 mL of methanol, 50 μL of 10% AlCl3, 50 μL of 1 M potassium acetate,
and 1.4 mL H2O. The mixture was incubated at room temperature for
30 min. Thereafter, the absorbance of the reaction mixture was subse-
quently measured at 415 nm. Quercetin was used as standard and the
total ﬂavonoid content was calculated as quercetin equivalent.
2.5. Nitric oxide (NO) radical scavenging activity
Nitric oxide radical scavenging assaywas performed using Griess re-
agent method [25]. Brieﬂy, 0.3 mL of sodium nitroprusside (5mM) was
added to 1mL of each of various volumes (0–400 μL) of the extract and/
or Vitamin C (Standard). The tubes were then incubated at 25 °C for
150 min. Thereafter, 0.5 mL of Griess reagent (prepared by equal vol-
ume of 1% sulphanilamide on 5% orthophosphoric acid and 0.01%
naphthyl ethylenediamine in distilled water, used after 12 h of prepara-
tion) was added. The absorbance was measured at 546 nm. NO radical
scavenging ability of the extract was calculated and expressed as per-
centage inhibition using the formula:
% Inhibition ¼ Absref–Abssamð Þ=Absref½   100 ð1Þ
where Absref is the absorbancewithout the extract and Abssam is the ab-
sorbance of the extracts.
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The method of Halliwell and Gutteridge [26] was used to determine
the ability of the extract to scavenge hydroxyl radical produced from
Fe2+/H2O2-induced decomposition of deoxyribose. The extract/Vitamin
C (standard) of various volumes (0–200 μL) was added to a reaction
mixture containing 120 μL of 20mMdeoxyribose, 400 μL of 0.1M phos-
phate buffer, and 40 μL of 500 μM of Fe2SO4, and the volume was made
up to 800 μLwith distilled water. The reactionmixture was incubated at
37 °C for 30 min and the reaction was then stopped by the addition of
0.5 mL of 28% trichloroacetic acid. This was followed by the addition
of 0.4 mL of 0.8% thiobarbituric acid solution. The tubes were subse-
quently incubated in boilingwater for 20min. The absorbancewasmea-
sured at 532 nm in a spectrophotometer. OH radical scavenging ability
was calculated using Eq. (1).
2.7. Fe2+ chelation assay
The Fe2+-chelating ability of the extracts was determined using a
slightly modiﬁed method [27,28]. Freshly prepared 500 μM FeSO4
(150 μL) was added to a reaction mixture containing 168 μL of 0.1 M
Tris–HCl (pH 7.4), 218 μL of saline (0.9%), and extracts and/or EDTA
(Standard) (0–100 μL). The reaction mixture was incubated for 5 min,
before the addition of 13 μL 0.25% 1,10-phenanthroline (w/v). The ab-
sorbance was subsequently measured at 510 nm in a spectrophotome-
ter. The Fe (II)-chelating ability was subsequently calculated (Eq. (1)).
2.8. Handling of experimental animals
Thirty adult male Wistar strain albino rats (weighing between 205
and 210 g) of about 6–7 weeks old were purchased from the animal
breeding colony of the Animal Production and Health, Federal Universi-
ty of Technology, Akure. Their handling was in accordance with the
Guide for Care and Use of Laboratory Animals prepared by the National
Academy of Science, published by theNational Institute of Health (USA)
[29]. The rats were allowed to acclimatize for 14 days andmaintained at
room temperature under laboratory conditions with access to standard
animal feed and water ad libitum.
2.9. Preparation of penile tissue homogenate and lipid peroxidation assay
The rats were decapitated under mild diethyl ether anaesthesia and
rapidly dissected. The penile tissue was rapidly removed and placed on
ice and weighed. This tissue was subsequently homogenized in cold sa-
line (1/10 w/v) with about 10-up-and-down strokes at approximately
107.34 g in a Teﬂon glass homogenizer. The homogenate was centri-
fuged for 10 min at 3000 g to yield a pellet that was discarded and a
low-speed supernatant (S1) that was kept for lipid peroxidation assay
[30]. Hundred microliters of penile homogenate supernatant was
mixed with a mixture containing 30 μL of 0.1 M Tris–HCl buffer
(pH 7.4), extract and/or EDTA (standard), and 30 μL of the pro-oxidant
(250 μMiron (II) sulphate). The volumewasmade upwith 300 μL of dis-
tilled water before incubation at 37 °C for 2 h. The colour reaction was
developed by adding 300 μL of 8.1% SDS (sodium dodecyl sulphate) to
the reaction mixture containing the homogenate, followed by the addi-
tion of 600 μL of acetic acid/HCl (pH 3.4) and 600 μL of 0.8% thiobarbitu-
ric acid (TBA). This mixture was incubated at 100 °C for 1 h. The
absorbance of thiobarbituric acid reactive species (TBARS) produced
was measured at 532 nm. MDA (malondialdehyde) produced was
expressed as % control [31].
2.10. Angiotensin-I converting enzyme (ACE) inhibition assay
The inhibition of ACE activity of the extract was determined accord-
ing to the describedmethod of Cushman andCheung [32]. Different vol-
umes (5–25 μL) of the extract or Captopril (Standard drug) and 50 μL ofpenile homogenate as a source for ACE (EC 3.4.15.1) were pre-
incubated at 37 °C for 15 min. Thereafter, enzymatic reaction was initi-
ated by adding 150 μL of 8.33 mM ACE substrate [hippuryl-l-histidyl-l-
leucine (HHL)] in 125 mM of Tris–HCl buffer (pH 8.3) to the reaction
mixture and incubated at 37 °C for 30 min. The reaction was stopped
by adding 250 μL of 1 M HCl. The hippuric acid (Bz-Gly) produced by
the reaction was extracted with 1.5 mL ethylacetate. The mixture was
then centrifuged to separate the ethyl acetate layer, after which the
1 mL of the ethyl acetate layer was transferred to a clean test tube and
evaporated to dryness. The residue was re-dissolved with distilled
water and its absorbance was measured at 228 nm. The control experi-
mentwas performedwithout the test sample. The percentage ACE inhi-
bition was subsequently calculated (Eq. (1)).2.11. Arginase inhibition assay
Penile homogenates were prepared by homogenizing 10 g (w/v) of
penile tissue in three volumes of homogenization cold buffer (phos-
phate buffer, pH 7.2). The homogenate was centrifuged for 20 min at
357.80 g and the supernatant was used as the source of enzyme. Argi-
nase activity was determined by the measurement of urea produced
by the reaction of Ehrlich's reagent. The reaction mixture contained in
ﬁnal concentration 1.0 mM Tris–HCl buffer, pH 9.5, containing 1.0 mM
MnCl 0.1 M arginine solution and 50 mM of the enzyme preparation
in a ﬁnal volume of 1.0 mL. The mixture was incubated for 10 min at
37 °C. The reaction was terminated by the addition of 2.5 mL Ehrlich re-
agent (2.0 g of p-dimethylaminobenzaldehyde in 20mL of absolute hy-
drochloric acid (37% purity) and made up to 100 mL with distilled
water). The optical density reading was taken after 20 min at 450 nm.
The control experimentwas performedwithout the test sample or stan-
dard and the arginase inhibitory activity was calculated (Eq. (1)) and
expressed as percentage inhibition [33].2.12. AChE inhibition assay
Penile homogenatewaspreparedbyhomogenizing 10 g (w/v) of pe-
nile tissue in three volumes of homogenization cold buffer (phosphate
buffer, pH 7.2). The homogenate was centrifuged for 20 min at
357.80 g and the supernatant was used as the source of enzyme. The
AChE activity was determined in a reaction mixture containing 200 μL
of the homogenate in 0.1 M phosphate buffer, pH 8.0, 100 μL of a solu-
tion of 5,5′-dithio-bis (2-nitrobenzoic) acid (DTNB 3.3 mM in 0.1 M
phosphate buffered solution, pH 7.0, containing NaHCO3 6 mM), ex-
tract/Prostigmine [standard AChE inhibitor (0–100 μL)] and 500 μL of
phosphate buffer, pH 8.0. After incubation for 20 min at 25 °C,
acetylthiocholine iodide (100 μL of 0.05 mM water solution) was
added as the substrate, and AChE activity was determined by UV spec-
trophotometry from the absorbance changes at 412 nm for 3.0 min at
25 °C. The AChE activity was expressed as percentage AChE inhibition
[34] following Eq. (1).2.13. Data analysis
The results of three replicate experiments were pooled and
expressed asmean± standard deviation (SD). One-way analysis of var-
iance (ANOVA) was used to analyse the mean and the post hoc treat-
ment was performed using Duncan multiple test [35]. Signiﬁcance
was accepted at P b 0.05. IC50 (extract concentration causing 50% effec-
tiveness) was calculated using non-linear regression with GraphPad
Prism version 5.00 for windows. Differences between groups of HPLC
were assessed by an analysis of variance model and Tukey's test. The
level of signiﬁcance for the analyses was set to P b 0.05. These analyses
were performed by using the free software R version 3.1.1.
Table 1
Phenolic acid and ﬂavonoid compositions of Ficus capensis leaves.
Components mg/g %
Gallic acid 51.19 ± 0.03 5.11
Catechin 12.75 ± 0.01 1.27
Chlorogenic acid 23.98 ± 0.02 2.39
Caffeic acid 30.67 ± 0.01 3.06
Ellagic acid 31.45 ± 0.03 3.14
Epicatechin 13.26 ± 0.02 1.32
Rutin 25.03 ± 0.01 2.5
Quercitrin 18.54 ± 0.02 1.85
Quercetin 49.07 ± 0.01 4.9
Kaempferol 6.15 ± 0.03 0.61
Values represent means ± standard deviation of triplicate readings.
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3.1. Phenolic constituents and total phenolic contents
TheHPLC–DAD analysis as presented in Table 1 revealed the presence
of phenolic acids such as gallic acid (51.19 mg/g), catechin (12.75 mg/g),
chlorogenic acid (23.98 mg/g), ellagic acid (31.45 mg/g), caffeic acid
(30.67 mg/g) and epicatechin (13.26 mg/g) and ﬂavonoids such as quer-
cetin (49.07mg/g), quercitrin (18.54mg/g), kaempferol (6.15mg/g), and
rutin (25.03mg/g). The results of the total phenol and ﬂavonoid contents
of the F. capensis leaf extract are presented in Table 2. The total phenol
content reported as gallic acid equivalent was 61.18 mg GAE/100 g,
while the total ﬂavonoid content reported as quercetin equivalent was
32.14 mg QUE/100 g.3.2. Radical scavenging and Fe2+ chelating abilities
The extract scavenged OH and NO radicals in a dose-dependent
manner as shown in Fig. 1a and b respectively with IC50 values of
0.53 mg/mL (OH radical) and 0.12 mg/mL (NO radical) (Table 2). Fig.
1c shows the Fe2+-chelating ability of the extract from F. capensis. The
extract was able to chelate Fe2+ in a dose-dependent manner with
IC50 = 0.16 mg/mL (Table 2).3.3. Inhibition of malondialdehyde production
The incubation of penile homogenate in the presence of Fe2+ caused
a signiﬁcant increase (P b 0.05) in themalondialdehyde (MDA) content
(153.08%) as shown in Fig. 1d. However, the addition of extract from
F. capensis leaves in a dose-dependent manner inhibited MDA levels
with IC50 = 435.17 μg/mL (Table 2).Table 2
Total phenol and ﬂavonoid contents and IC50 values of NO and OH radical scavenging and
Fe2+-chelating abilities, ACE, AChE, arginase and Fe2+-induced lipid peroxidation inhibi-
tion by F. capensis phenolic extract.
Parameters Values
Total phenolic (gallic acid equivalent) (mg/100 g) 61.18 ± 0.30
Total ﬂavonoid content (quercetin equivalent) (mg/100 g) 32.14 ± 0.16
NO radical scavenging ability (mg/mL) 0.12 ± 0.01
OH radical scavenging ability (mg/mL) 0.53 ± 0.00
Fe2+ chelating ability (mg/mL) 0.16 ± 0.00
Inhibition of Fe2+-induced lipid peroxidation (μg/mL) 435.17 ± 4.18
Inhibition of ACE activity (μg/mL) 52.17 ± 6.46
Inhibition of AChE activity (μg/mL) 172.60 ± 8.79
Inhibition of arginase activity (μg/mL) 112.50 ± 7.03
Values represent means ± standard deviation of triplicate readings.3.4. Effects of the extract on ACE, AChE and arginase activities
The interaction of the extract with ACE as shown in Fig. 1e revealed
that the extract inhibited ACE (IC50 = 52.17 μg/mL) activity in a dose-
dependent. Also, the result in Fig. 1f revealed that the extract inhibited
AChE activity in a dose-dependent manner with IC50 = 579.63 μg/mL
(Table 2). Furthermore, extract inhibited arginase activity in a dose-
dependent manner with IC50 = 112.50 μg/mL (Table 2).
4. Discussion
F. capensis is known with various medicinal beneﬁts which have
been attributed to its phytochemicals such as phenolic compounds
[20]. Study has revealed that phenolics of medicinal plants are related
to their antioxidant capacity [36]. The result obtained in this study
shows that the studied extract exhibited hydroxyl (OH) and nitric
oxide (NO) radical scavenging abilities. In biological system, hydroxyl
radical (OH) could be generated from superoxide anion and hydrogen
peroxide by the Haber–Weiss reaction or from hydrogen peroxide via
the Fenton reaction [37]. OH radical is highly reactive, energetic, short
live and very toxic to cells [38], and played a signiﬁcant role in
diabetes-associated ED [39,40]. Nitric oxide (NO) radical is capable of
mediating many cytotoxic and pathological processes and could con-
tribute in part to the formation of plaque in penile tissues. This radical
is usually generated in response to inﬂammation [41]. Although NO is
required for the initiation of penile erection but can also combine with
superoxide (O2−) to form peroxynitrite: a cytotoxic compound that is
capable of inducing the formation of lipid peroxidation and nitration,
which leads to the formation of malondialdehyde and hydroperoxides:
a risk factor in pathophysiology of ED [5,42,43]. Therefore, radical
scavenging abilities of the studied extract as revealed in this study
could be beneﬁcial in the management of ED and could be attributed
to the presence of polyphenols [44].
The disruption of iron balance in the body system can bring about
iron overload: another culprit in oxidative stress-induced ED [42]. Iron
overload increases the formation of reactive oxygen species (ROS)
which could induce initiation of lipid peroxidation [45]. Iron II (Fe2+)
reacts with H2O2 in the Fenton reaction to produce the highly reactive
hydroxyl radical, which can damage proteins, lipids, and nucleic acids.
Our ﬁndings in this study revealed that extract from F. capensis leaves
chelated Fe2+ in a dose-dependent pattern. This chelating ability
might be due to the presence of polyphenols. Phenolic compounds can
form a complex with iron thereby aiding its excretion from the body.
Fe2+-chelating ability of extract could therefore be beneﬁcial in the
management/prevention of ED [46]. Our previous research has showed
that phenolic compounds such as gallic acid, chlorogenic acid, catechin,
kaempferol, quercetin, and quercitrin are capable of chelating metallic
ion [47].
Superoxide anions and other reactive oxygen species (ROS) have
been shown to be a major contributor to the pathogenesis of ED via
the initiation of lipid peroxidation [48,49]. Increase inmalondialdehyde
(MDA) content when rat penile homogenate was incubated with Fe2+
could be through the breakdown of hydrogen peroxide to generate
OH radical [50]. Fe2+-induced lipid peroxidation and oxidative stress
have been reported to cause injuries to the penile tissue [51–53]. How-
ever, the inhibition of MDA production caused by the extract from
F. capensis leaves could be attributed to the ability of the extract to che-
late Fe2+ and scavenged radicals thus preventing the initiation of oxida-
tive damage [54].
Some experimental investigations have revealed that increase in
blood pressure could be linked with ED [55]. Therefore inhibition of
ACE which catalyses the conversion of angiotensin I to angiotensin II
has marked therapeutic effects in the management of high blood pres-
sure and consequently activating the release of NO which improves
erectile function. Furthermore, the inhibition of ACE activates bradyki-
nin which has been implicated in erectile function [5,54]. The observed
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Fig. 1. (a) Nitric oxide (NO) radical scavenging ability; (b) hydroxyl (OH) radical scavenging ability; (c) Fe2+-chelating ability, (d) Fe2+-induced MDA inhibition in rat penile tissue
homogenate, (e) ACE inhibitory ability, (f) AChE inhibitory ability, (g) arginase inhibitory ability of extract from F. capensis leaves. Values represent means ± standard deviation of
triplicate readings.
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tile function. Previous report has shown that phenolics can interactwith
disulphide bridges of the ACE enzyme thereby modifying the structure
and reducing its activity [55]. Moreover, Oboh and Rocha [16] also re-
ported that phenolic extract from Moringa oleifera leaves inhibited
ACE activity.
The penile physiological states of ﬂaccidity or erection result from
the contraction or relaxation, respectively, of smooth muscle cells in
the penile corpora cavernosa. On sexual stimulation the cavernous
nerves release ACh that could stimulate the release of NO [8]. Therefore,
the observed inhibitory effects of the studied extract on AChE, an en-
zyme that causes hydrolysis of ACh could contribute to erectile function
of the sample extract [6].
Decrease in NO bioavailability due to endothelial dysfunction or
nerve injury is a major predisposing factor for ED [55]. An increased
level of arginase is common among patients with ED which could be a
consequence reducing the biosynthesis of nitric oxide (NO) via the
NO–cGMP pathway [56]. Thus, dose-dependent inhibition of arginase
activity by the studied extract could be of great importance in theman-
agement of ED as this could increase genital blood ﬂow during sexual
arousal. The inhibitory properties of the extract could be attributed to
the phenolic components. Polyphenols have been reported to possess
inhibitory effects on arginase activity [4,57]. More so, ﬂavonoids such
as catechin, epicatechin, and quercetin and its derivatives (quercitrin
and isoquercitrin) have shown to be strong inhibitors of arginase activ-
ity and could be linked to the formation of hydrogen bond and hydro-
phobic interactions between these polyphenolic compounds and the
hydrophobic active site of the enzyme [4,57].
5. Conclusion
The antioxidant properties andACE, AChE and arginase inhibitory ef-
fects of extract from F. capensis leaves could be therapeutic points in the
management of ED. These ﬁndings revealed the possible mechanism of
action of the F. capensis leaf in the management/treatment of ED. How-
ever, this health promoting effect is suggested to be a function of its
phenolic compounds.
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